Your account is not claimed yet. You can sign up with ORCID to claim your account.

Yitian Xu

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Venues

PLoS pathogens

Cancer research

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Cornell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Cornell University Aug 22o 2013 - May 29o 2018

United States

PHD

Publications

Kai Sun, Yitian Xu, Licheng Zhang, Polly A Niravath, Jorge G Darcourt, Tejal Patel, Bin S Teh, Andrew M Farach, Carlo Guerrero, Sunil Mathur, Mark A Sultenfuss, Nakul Gupta, Mary R Schwartz, Susan L Haley, Sindhu Nair, Xiaoxian Li, Thi Truc Anh Nguyen, Joseph D Butner, Joe E Ensor, Jaime A Mejia, Zhuyong Mei, E Brian Butler, Shu-Hsia Chen, Eric H Bernicker, Jenny C Chang
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Yitian Xu, Licheng Zhang, Jose Thaiparambil, Sunny Mai, Dimuthu Nuwan Perera, Jilu Zhang, Ping-Ying Pan, Cristian Coarfa, Kenneth Ramos, Shu-Hsia Chen, Randa El-Zein
Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles. Cancer research communications 2 (8) (2022)
Swarnima Singh, Nigel Lee, Diego A Pedroza, Igor L Bado, Clark Hamor, Licheng Zhang, Sergio Aguirre, Jingyuan Hu, Yichao Shen, Yitian Xu, Yang Gao, Na Zhao, Shu-Hsia Chen, Ying-Wooi Wan, Zhandong Liu, Jeffrey T Chang, Daniel Hollern, Charles M Perou, Xiang H F Zhang, Jeffrey M Rosen
Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer. Cancer research 82 (12) (2022)
Andrew W Chung, Kartik Anand, Ann C Anselme, Alfred A Chan, Nakul Gupta, Luz A Venta, Mary R Schwartz, Wei Qian, Yitian Xu, Licheng Zhang, John Kuhn, Tejal Patel, Angel A Rodriguez, Anna Belcheva, Jorge G Darcourt, Joe E Ensor, Eric H Bernicker, Ping-Ying Pan, Shu-Hsia Chen, Delphine J Lee, Polly A Niravath, Jenny C Chang
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer. Science translational medicine 13 (624) (2021)
Yitian Xu, Lu Huang, Jonathan L Kirschman, Daryll A Vanover, Pooja Munnilal Tiwari, Philip J Santangelo, Xiling Shen, David G Russell
Exploitation of Synthetic mRNA To Drive Immune Effector Cell Recruitment and Functional Reprogramming In Vivo. Journal of immunology (Baltimore, Md. : 1950) 202 (2) (2018)
Yitian Xu, Lihua Wang, Matthew D Zimmerman, Kai-Yuan Chen, Lu Huang, Dah-Jiun Fu, Firat Kaya, Nikolai Rakhilin, Evgeniya V Nazarova, Pengcheng Bu, Veronique Anne Dartois, David G Russell, Xiling Shen
Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis. PLoS pathogens 14 (4) (2018)

Yitian Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yitian Xu